Respiratory Medicine

The Department of Respiratory Medicine at Hangzhou Xixi Hospital was established in October 2018. The department currently has 32 open beds, 2 chief physicians, 1 deputy chief physician, and 6 attending physicians; 6 staff members hold master's degrees or higher, and the nursing team consists of 13 members, including 6 nurse supervisors, 5 nurse practitioners, and 2 nurses. The department has a specialized respiratory ward, a sleep monitoring room, a pulmonary function room, and a bronchoscopy examination room. Its key research areas include COVID-19-related pulmonary diseases, chronic obstructive pulmonary disease (chronic bronchitis and emphysema), pulmonary heart disease, acute/chronic respiratory failure, obstructive sleep apnea syndrome, pulmonary infections, pleural infections, pleural effusion, pneumothorax, pulmonary embolism, and others. In recent years, the discipline has developed rapidly. In particular, during the COVID-19 period, the Department of Respiratory Medicine played a crucial role in the treatment and nursing care of COVID-19 patients. It adopted multidisciplinary collaboration and integrated traditional Chinese and Western medicine, and, with the aid of various methods including epidemiological investigation, laboratory testing, clinical observation, pathological examination, and radiological examination, established effective treatment plans and made a significant contribution to the fight against the COVID-19 pandemic.